Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jun;12(2):189-91.
doi: 10.1007/s13181-016-0537-9. Epub 2016 Feb 8.

Acute on Chronic Ivabradine Overdose: a Case Report

Affiliations
Case Reports

Acute on Chronic Ivabradine Overdose: a Case Report

Kevin Maskell et al. J Med Toxicol. 2016 Jun.

Abstract

Ivabradine is a newly approved medication which reduces the heart rate by antagonizing the If channel. We report a case of intentional overdose on ivabradine. A 26-year-old female presented after taking 250 mg ivabradine. On arrival, her vital signs and neurologic exam were unremarkable. Within 30 min, her heart rate decreased to 31 bpm, but she remained normotensive with no change in mentation. Her bradycardia resolved after treatment with atropine. She experienced two further bradycardic episodes responsive to atropine; the second episode was associated with hypotension, responsive to a fluid bolus. For the remainder of her hospitalization, she remained hemodynamically stable without further interventions. She was dispositioned to the psychiatry service approximately 36 h post-ingestion with a heart rate of 67 bpm. Laboratory analysis confirmed a serum ivabradine concentration of 525 ng/mL, greater than 50 times the mean level in therapeutic trials. Proposed treatments for ivabradine include activated charcoal, atropine, isoproterenol, and intravenous pacing. Further study is needed to identify ideal treatment modalities.

Keywords: Bradycardia; Cardiotoxicant; Ivabradine.

PubMed Disclaimer

References

    1. Traynor K. Ivabradine approved for stable chronic heart failure. Am J Health Syst Pharm. 2015;72(11):896. - PubMed
    1. Mathiaux F, Dulaurent S, Julia F, Gaulier JM. Case report of ivabradine intoxication. J Anal Toxicol. 2014;38(4):231–232. doi: 10.1093/jat/bku015. - DOI - PubMed
    1. Gomez Casal V, Lage Cendon L, Lago Preciado G, Vara Adrio S. Ivabradine poisoning with suicide intention. Med Intensiva. 2015;39:577–9. http://www.medintensiva.org/es/pdf/S0210569115001072/S200/. doi: S0210-5691(15)00107-2. - PubMed
    1. Hancox J, Melgari D, Dempsey C, Brack K, Mitcheson J, Ng GA. hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes. Ther Adv Drug Saf. 2015;6(4):177. doi: 10.1177/2042098615595546. - DOI - PMC - PubMed
    1. Nawarskas JJ, Bowman BN, Anderson JR. Ivabradine: a unique and intriguing medication for treating cardiovascular disease. Cardiol Rev. 2015;23(4):201–211. doi: 10.1097/CRD.0000000000000070. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources